title: Interferon therapy for Ph1-positive chronic myelogenous leukaemia patients relapsing after T-cell depleted allogeneic bone marrow transplantation.
authors.affiliation: Department of Human Biopathology, University La Sapienza, Rome, Italy.
authors.forename: W
authors.initials: W
authors.lastname: Arcese
authors.forename: F R
authors.initials: FR
authors.lastname: Mauro
authors.forename: M
authors.initials: M
authors.lastname: Screnci
authors.forename: G
authors.initials: G
authors.lastname: Alimena
authors.forename: F
authors.initials: F
authors.lastname: Lo Coco
authors.forename: A P
authors.initials: AP
authors.lastname: Iori
authors.forename: M R
authors.initials: MR
authors.lastname: de Cuia
authors.forename: P
authors.initials: P
authors.lastname: Fazi
authors.forename: E
authors.initials: E
authors.lastname: Montefusco
authors.forename: F
authors.initials: F
authors.lastname: Mandelli
mesh_terms: D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation; D002648:Child; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D008297:Male; D010677:Philadelphia Chromosome; D011994:Recombinant Proteins
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins